SINGAPORE, Sept. 20, 2011 /PRNewswire-Asia/ -- The high growth of the biopharmaceutical market in Asia is creating a strong need for production of biopharmaceuticals at higher qualities and volumes, as well as developing an effective and efficient bioprocess. Over the past few years, as upstream operations continue to improve, the ability of current downstream facilities to handle the additional load has led to strains and constrictions.
From a recent exclusive interview with Sudip Kumar Majumder, Principal Scientist at Intas Biopharmaceuticals India, it is clear that innovations aimed at streamlining and redesigning downstream processes will change the current state of play for the biopharmaceutical industry.
Sudip Kumar Majumder will be discussing on how you can re-design downstream processes for better process economy and regulatory compliance at the Downstream Bioprocessing & Single-Use Systems Asia 2011conference.
Join leading experts at Downstream Bioprocessing & Single-Use Systems Asia 2011 to discuss bestpractices of process optimization and the latest technologies in downstream bioprocessing.
Expert speakers from the downstream bioprocessing space include:
*Visit www.downstreambioprocessing.com for the full list of speakers.
Find out suitable technical solutions and logical purification sequences to improve production process performance, reduction of development time and thereby time to market introduction.
Downstream Bioprocessing & Single-Use Systems Asia 2011 will be held at Amara Hotel, Singapore on 1 December 2011, together with a post-conference workshop on 2 December 2011.
Drop an email to [email protected] to register for the event or visit www.downstreambioprocesing.com for more information.
SOURCE　International Quality and Productivity Center (IQPC Worldwide Pte Ltd)